MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Monday, February 9, 2015

BRING IT ON -- A Special Multiple Sclerosis Q&A program from Davie, Florida

Program Date: February 7, 2015

This Q&A was made possible by all the questions brought by the MS Patients and Caregivers that attended this program as well as the many that sent their questions by email or via social media.

Questions ranged from topic relating to MS medications, Symptoms like cognition, Alternative Therapies and many concerning Social Security disability law as well.

Watch this program at your leisure. It is approx. 2 hours in length but here, you can pause at anytime and resume when you can.

PLEASE share this video with others that have MS, caregivers and healthcare providers. 

This MS Views and News, MS Q&A program was well received and appreciated, as mentioned by many as they left for the day..... 

To know more of MS Views and News and the educational programs we provide and to have access to our every-other -week e-Newsletters, then please click - to opt-in

 Keep CURRENT with MS Views and NewsOPT-IN here


No comments: